About Thomas Remy
Thomas Remy is the Business Unit Director for Hospital Care at Baxter S.A.S., France from 2007 till April 2009. He was responsible for managing the sales and marketing of parenteral nutrition products (Oliclinomel, Cernevit), anesthesia products (Suprane, Brevibloc), oncology products (Endoxan, Holoxan), biosurgery products (Tissucol, Floseal), IV solutions and sets, and infusors. Prior to this
Thomas Remy ’s experience
Clinical Research Associate/ Scientist
at
Baxter
, Paris, France
September 2007 – Currently Working
Industry: Pharma/Biotech/Clinical Research
Functional area: Pharma / Biotech / Healthcare / Medical / R&D
Business Unit Director at Baxter France with P&L full
responsibility for a range of hospital drugs and devices.
Thomas Remy ’s education
doctor [industry],
university of pharmacy [1985/June]
, Lille
Thomas Remy ’s additional information
Login to view additional information of Thomas Remy